HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Tang Selected Research

minaprine (Cantor)

7/2018Cinobufacini inhibits epithelial-mesenchymal transition of human hepatocellular carcinoma cells through c-Met/ERK signaling pathway.
2/2014The supercritical CO₂ extract from the skin of Bufo bufo gargarizans Cantor blocks hepatitis B virus antigen secretion in HepG2.2.15 cells.
2/2012Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells.
7/2010Apoptosis-inducing activity of compounds screened and characterized from cinobufacini by bioassay-guided isolation.
4/2010Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Tang Research Topics

Disease

250Neoplasms (Cancer)
08/2022 - 05/2003
57Hepatocellular Carcinoma (Hepatoma)
05/2022 - 02/2003
52Inflammation (Inflammations)
08/2022 - 05/2004
46Schizophrenia (Dementia Praecox)
08/2022 - 09/2005
40Infections
01/2022 - 09/2005
39Breast Neoplasms (Breast Cancer)
01/2022 - 10/2006
38Neoplasm Metastasis (Metastasis)
11/2022 - 05/2003
22Asthma (Bronchial Asthma)
02/2022 - 05/2004
21Carcinoma (Carcinomatosis)
01/2021 - 01/2004
19Prostatic Neoplasms (Prostate Cancer)
11/2022 - 05/2010
17Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 12/2009
16Carcinogenesis
01/2022 - 09/2003
15Autoimmune Diseases (Autoimmune Disease)
01/2022 - 08/2011
12Hypoxia (Hypoxemia)
03/2022 - 01/2013
12COVID-19
10/2021 - 01/2020
12Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2006
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2015
11Hypersensitivity (Allergy)
12/2021 - 05/2005
11Leukemia
01/2021 - 04/2004
11Alzheimer Disease (Alzheimer's Disease)
01/2020 - 04/2013
11Stomach Neoplasms (Stomach Cancer)
07/2018 - 08/2008
10Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2014
10Lung Neoplasms (Lung Cancer)
01/2022 - 09/2015
10Glioma (Gliomas)
01/2022 - 03/2005
10Liver Neoplasms (Liver Cancer)
10/2021 - 05/2003
10Arthritis (Polyarthritis)
03/2021 - 07/2006
10Cognitive Dysfunction
01/2021 - 08/2012
10Insulin Resistance
03/2020 - 04/2012
9Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 12/2009
9Fibrosis (Cirrhosis)
02/2022 - 04/2007
9Lymphatic Metastasis
04/2016 - 01/2005
8Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2013
8Pneumonia (Pneumonitis)
01/2022 - 11/2015
8Pain (Aches)
11/2021 - 12/2010
8Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 01/2018
8Respiratory Syncytial Virus Infections
01/2021 - 11/2015
8Body Weight (Weight, Body)
01/2021 - 04/2007
8Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017 - 06/2006
8Sarcoma 180
05/2010 - 01/2008
7Wounds and Injuries (Trauma)
12/2022 - 10/2006
7Hemorrhage
07/2022 - 12/2014
7Ulcerative Colitis
01/2022 - 10/2018
7Hyperglycemia
12/2021 - 08/2013
7Diabetes Mellitus
12/2021 - 01/2011
7Adenocarcinoma of Lung
01/2021 - 12/2014
7Colitis
03/2020 - 11/2014
7Adenocarcinoma
01/2020 - 01/2006

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
08/2022 - 05/2003
51Pharmaceutical PreparationsIBA
08/2022 - 01/2004
36Biological ProductsIBA
01/2022 - 04/2005
35Biomarkers (Surrogate Marker)IBA
08/2022 - 06/2005
33EnzymesIBA
05/2022 - 09/2007
26Glucose (Dextrose)FDA LinkGeneric
03/2022 - 11/2009
25CytokinesIBA
08/2022 - 05/2006
25Therapeutic UsesIBA
01/2022 - 09/2006
24Messenger RNA (mRNA)IBA
01/2021 - 01/2004
16Antiviral Agents (Antivirals)IBA
01/2022 - 04/2010
16AntigensIBA
01/2022 - 05/2004
14Interleukin-17 (Interleukin 17)IBA
08/2022 - 08/2009
13Oxygen (Dioxygen)IBA
03/2022 - 04/2008
13Long Noncoding RNAIBA
01/2022 - 01/2016
13ProgranulinsIBA
12/2018 - 04/2011
11MicroRNAs (MicroRNA)IBA
01/2022 - 11/2011
11Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 04/2009
11huachansuIBA
07/2018 - 01/2010
11MucinsIBA
08/2014 - 09/2005
10Interleukin-6 (Interleukin 6)IBA
08/2022 - 12/2008
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2011
10NitrogenIBA
01/2022 - 08/2011
10beta-aminoarteether maleateIBA
10/2021 - 12/2009
9Small Interfering RNA (siRNA)IBA
08/2022 - 09/2007
9ErbB Receptors (EGF Receptor)IBA
10/2021 - 05/2019
9RNA (Ribonucleic Acid)IBA
01/2021 - 09/2012
9LipidsIBA
01/2021 - 03/2008
9Olanzapine (Zyprexa)FDA Link
12/2020 - 07/2017
9acarboxyprothrombin (PIVKA)IBA
12/2011 - 05/2003
8Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
02/2022 - 08/2009
8Phosphotransferases (Kinase)IBA
01/2022 - 01/2011
8Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2015
8Glutathione (Reduced Glutathione)IBA
01/2022 - 08/2006
8artemisinin (artemisinine)IBA
10/2021 - 01/2012
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2011
8Monoclonal AntibodiesIBA
01/2021 - 02/2003
8Interleukin-10 (Interleukin 10)IBA
01/2021 - 05/2007
7InterferonsIBA
08/2022 - 09/2008
7AcidsIBA
05/2022 - 07/2005
7Membrane Transport Proteins (Biological Pump)IBA
12/2021 - 10/2014
71-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2021 - 03/2005
7HomocysteineIBA
02/2021 - 11/2006
7Indicators and Reagents (Reagents)IBA
01/2021 - 01/2006

Therapy/Procedure

85Therapeutics
05/2022 - 03/2005
30Drug Therapy (Chemotherapy)
11/2021 - 01/2008
12Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2021 - 04/2010
11Precision Medicine
01/2020 - 09/2015
10Radiotherapy
01/2022 - 09/2013
10Photochemotherapy (Photodynamic Therapy)
02/2021 - 03/2005
9Hematopoietic Stem Cell Transplantation
04/2022 - 05/2011
8Length of Stay
07/2022 - 10/2013
7Lasers (Laser)
03/2022 - 11/2013
7Aftercare (After-Treatment)
07/2021 - 04/2008